U.S. Stem Cell, Inc.
USRM
$0.0001
$0.000.00%
12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
---|---|---|---|---|---|
Net Income | -566.60K | -565.40K | -570.10K | -1.16M | -641.00K |
Total Depreciation and Amortization | -- | -- | -- | -- | -- |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 469.90K | 437.60K | 429.10K | 931.20K | 396.40K |
Change in Net Operating Assets | 53.60K | 63.10K | 7.70K | 160.80K | 27.90K |
Cash from Operations | -43.10K | -64.70K | -133.30K | -63.80K | -216.70K |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -- | -- | -- | -- | -- |
Total Debt Issued | 19.50K | 36.00K | 120.70K | 37.00K | 17.00K |
Total Debt Repaid | -1.50K | -1.50K | -1.50K | -23.10K | -16.20K |
Issuance of Common Stock | 0.00 | 50.00K | 10.00K | 25.00K | 225.00K |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 18.00K | 84.50K | 129.20K | 38.90K | 225.80K |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -25.00K | 19.80K | -4.10K | -24.90K | 9.10K |